Skip to main content

Illumina to Provide SNP Genotyping Services for GlaxoSmithKline

NEW YORK, June 29 – Illumina will provide SNP genotyping services on a set of samples provided by GlaxoSmithKline, the companies said Friday. 

The agreement calls for Illumina to apply its BeadArray technology to determine the frequency of specific SNPs in the GlaxoSmithKline samples. The companies did not disclose further details.

Illumina’s SNP scoring technology is based on a technique, developed together with Applied Biosystems, for attaching strands of DNA to beads, which are then placed in an indentation on the tip of a fiber optic bundle. The company arrays these bundles onto a cassette that matches up with a standard 96-well microtiter plate. 

Chevron has also commissioned Illumina to study how the BeadArray technology could be applied to detecting certain compounds in hydrocarbon processing operations.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.